Rectal and Colon Cancer Treatment Guidelines

Introduction to Treatment Approaches

The National Comprehensive Cancer Network recommends that rectal cancer requires locoregional therapy (neoadjuvant chemoradiotherapy or short-course radiotherapy) in addition to surgery for stage II/III disease, while colon cancer treatment focuses primarily on surgery followed by adjuvant chemotherapy to prevent distant metastases, without routine radiotherapy 1, 2

For clinical stage II or III rectal cancer, total neoadjuvant therapy (TNT) is now the preferred approach, delivering both chemoradiotherapy and chemotherapy before surgery, according to the National Comprehensive Cancer Network 2
The American Cancer Society suggests that total mesorectal excision (TME) is mandatory for all rectal lesions not amenable to local excision, and complete excision of the mesorectum is essential for tumors of the lower third of the rectum to reduce locoregional recurrence 5, 3
Sphincter preservation should be attempted whenever possible, depending on tumor location relative to the sphincter, tumor volume, and patient anatomy, as recommended by the British Journal of Cancer 5, 7

The National Comprehensive Cancer Network recommends that surgical resection is the initial treatment without preoperative radiotherapy or chemotherapy for most colon cancers, and adjuvant chemotherapy is the cornerstone for node-positive (stage III) disease to prevent distant metastases 1, 3
Radiotherapy is not routinely used in colon cancer management due to lower local recurrence rates, according to the National Comprehensive Cancer Network 1

For rectal cancer with resectable metastases, short-course radiotherapy (5×5 Gy) followed by combination chemotherapy, then surgical resection of both primary and metastatic sites is recommended, as suggested by the Praxis Medical Insights 4
For colon cancer with resectable metastases, upfront surgical resection of both primary and metastatic disease is typically performed, with perioperative chemotherapy (FOLFOX or CAPEOX) being standard, according to the Praxis Medical Insights 4

For rectal cancer follow-up, clinical examination, chest X-ray, liver ultrasound, and colonoscopy are standard, and if sphincter-preservation surgery was performed, rectoscopy and/or endorectal ultrasonography should be considered, as recommended by the British Journal of Cancer 5, 3
For colon cancer follow-up, similar surveillance with clinical examination, CEA monitoring, CT imaging, and colonoscopy is recommended, and pelvic imaging is not routinely required unless there was direct pelvic involvement at diagnosis, according to the Praxis Medical Insights 3